Multi-kinase inhibition in ovarian cancer

Por Dent, Paul
Publicado em 2014

ERK plays the baddie (again)

Por Dent, Paul
Publicado em 2013

Arsenic in leukemia: A RSKy business

Por Dent, Paul
Publicado em 2013

PARP inhibitors are not all equal

Por Dent, Paul
Publicado em 2013

Janus-faced Kupffer cells in tumor metastasis

Por Dent, Paul
Publicado em 2013

Multi-kinase modulation for colon cancer therapy

Por Dent, Paul
Publicado em 2013

Non-canonical p53 signaling to promote invasion

Por Dent, Paul
Publicado em 2013

Ceramide in the prostate

Por Dent, Paul
Publicado em 2013

The flip side of doxorubicin: Inflammatory and tumor promoting cytokines

Por Dent, Paul
Publicado em 2013

HDACIs and the inhibition of invasive potential

Por Dent, Paul
Publicado em 2013

The multi-hit hypothesis in basal-like breast cancer

Por Dent, Paul
Publicado em 2013

FADD the bad in head and neck cancer

Por Dent, Paul
Publicado em 2013

Not so WEE: Targeting G(2)/M to kill mesothelioma cells

Por Dent, Paul
Publicado em 2014

Crosstalk between ERK, AKT, and cell survival

Por Dent, Paul
Publicado em 2014

Met in lung cancer

Por Dent, Paul
Publicado em 2014

New methods to control neuroblastoma growth

Por Dent, Paul
Publicado em 2014

Repurposing Tecfidera for cancer

Por Booth, Laurence, Malkin, Mark, Dent, Paul
Publicado no Aging (Albany NY) (2016)

HSPA5/Dna K May Be a Useful Target for Human Disease Therapies

Por Booth, Laurence, Roberts, Jane L., Dent, Paul
Publicado no DNA Cell Biol (2015)

Blockade of Histone Deacetylase Inhibitor-Induced RelA/p65 Acetylation and NF-κB Activation Potentiates Apoptosis in Leukemia Cells through a Process Mediated by Oxidative Damage,...

Por Dai, Yun, Rahmani, Mohamed, Dent, Paul, Grant, Steven
Publicado em 2005

2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process

Por Gao, Ning, Rahmani, Mohamed, Dent, Paul, Grant, Steven
Publicado em 2005